Strategic Partnerships

Foundation Medicine collaborates with academic and commercial organizations that share in our vision of a transformation in cancer care driven by a deep understanding of cancer genomics.

Foundation Medicine is collaborating with nearly 20 biotech and pharmaceutical companies to help accelerate the development of new targeted therapies. Utilizing our molecular information platform, we enable better selection of drug candidates, a better understanding of mechanisms of sensitivity or resistance, more efficient clinical trial design and faster patient recruitment into clinical trials. Ultimately, we believe these partnerships will accelerate the delivery of safe, effective targeted therapies available for patients with cancer.